Guangzhou Pluslife Biotech Co., Ltd.
PrivateLast Round
Series B
Nov 19, 2025
Total Funding Raised
$37.56M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Guangzhou Pluslife Biotech Co., Ltd. is a biotechnology company that specializes in the research, development, and manufacturing of advanced molecular point-of-care testing diagnostic systems.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guangzhou Pluslife Biotech Co., Ltd. Comparables
Compare Guangzhou Pluslife Biotech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ustar Biotechnologies (Hangzhou) Ltd. | 88% | |
| Coyote Bioscience Co., Ltd. | 82% | |
| Aptitude Medical | 80% |
Guangzhou Pluslife Biotech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 19, 2025 | ||||
| Grant | Oct 1, 2025 | ||||
| Grant | Nov 1, 2024 |
Guangzhou Pluslife Biotech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gates Foundation | Grant |
| Puhua Capital | Series B |
| Qiming Venture Partners | Series B |
| Guangzhou Guoju Venture Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Grew 22% QoQ, from 37 to 45 employees.
- Mar 25, 2026
Grew 19% QoQ, from 31 to 37 employees.
Guangzhou Pluslife Biotech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Guangzhou Pluslife Biotech Co., Ltd.'s valuation, stock price, and market status.
Is Guangzhou Pluslife Biotech Co., Ltd. a public or private company?
Guangzhou Pluslife Biotech Co., Ltd. is a private company.
What is the current stock price of Guangzhou Pluslife Biotech Co., Ltd.?
Guangzhou Pluslife Biotech Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Guangzhou Pluslife Biotech Co., Ltd. worth (valuation)?
Valuation information for Guangzhou Pluslife Biotech Co., Ltd. is not publicly available.
Can I buy Guangzhou Pluslife Biotech Co., Ltd. stock?
Guangzhou Pluslife Biotech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Guangzhou Pluslife Biotech Co., Ltd.'s last funding round?
Guangzhou Pluslife Biotech Co., Ltd.'s most recent funding round was Series B on November 19, 2025.
Who are the main investors in Guangzhou Pluslife Biotech Co., Ltd.?
Key investors in Guangzhou Pluslife Biotech Co., Ltd. include Gates Foundation, Guangzhou Guoju Venture Capital.
Will Guangzhou Pluslife Biotech Co., Ltd. IPO soon?
No public IPO plans have been announced for Guangzhou Pluslife Biotech Co., Ltd..
How can I track Guangzhou Pluslife Biotech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Guangzhou Pluslife Biotech Co., Ltd.'s secondary market activity and sign up for updates.